Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A molecular biological study of anti-tumor mechanisms of an anti-cancer agent Oxaliplatin against established human gastric cancer cell lines

1 Nov 2003

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Fungal Plant Pathogen Control
Share to Metal complexes synthesis and properties
Share to PI3K/AKT/mTOR signaling in cancer

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 14652166
DOI: 10.1016/s0753-3322(03)00027-1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A molecular biological study of anti-tumor mechanisms of an anti-cancer agent Oxaliplatin against established human gastric cancer cell linesPMID 14652166Read ↗

Molecular Target and Action Mechanism of Anti-Cancer AgentsSemantic proximity Read ↗

The FOXM1-induced resistance to oxaliplatin is partially mediated by its novel target gene Mcl-1 in gastric cancer cellsSemantic proximity Read ↗

The cellular pharmacology of oxaliplatin resistanceSemantic proximity Read ↗

Oxaliplatin Compromised CDK1 Activity Sensitizes BRCA-Proficient Cancers to PARP Inhibition in Oxaliplatin Resistance Gastric CancerSemantic proximity Read ↗

ANXA1 Induces Oxaliplatin Resistance of Gastric Cancer through Autophagy by Targeting PI3K/AKT/mTORSemantic proximity Read ↗

Pharmacogenomic approach for the identification of novel determinants of acquired resistance to oxaliplatin in colorectal cancerSemantic proximity Read ↗

The expression of Lin28 in gastric cancer cells treated with an anticancer bioactive peptide combined with oxaliplatin in vitro and in vivoSemantic proximity Read ↗

miR-193a-5p as a promising therapeutic candidate in colorectal cancer by reducing 5-FU and Oxaliplatin chemoresistance by targeting CXCR4Semantic proximity Read ↗

Oxaliplatin activity in selected and unselected human ovarian and colorectal cancer cell linesSemantic proximity Read ↗

LncRNA NORAD Promotes Oxaliplatin Resistance in Adenocarcinoma of Esophagogastric Junction via Sponging miR-433-3p and Activating AutophagySemantic proximity Read ↗

Functional Genomics Reveals Diverse Cellular Processes That Modulate Tumor Cell Response to OxaliplatinSemantic proximity Read ↗

Targeting type Iγ phosphatidylinositol phosphate kinase overcomes oxaliplatin resistance in colorectal cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.